Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

HPV Message Testing and Social Media Campaign

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03747302
Recruitment Status : Enrolling by invitation
First Posted : November 20, 2018
Last Update Posted : August 14, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Norris Cotton Cancer Center
Information provided by (Responsible Party):
Ardis Olson, MD, Trustees of Dartmouth College

Brief Summary:
This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively—many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Condition or disease Intervention/treatment Phase
Vaccine Human Papilloma Virus Other: Social Media Message about HPV and HPV vaccine Other: Social media message about risk of electronic cigarettes. Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Participants are not aware of which arm of social messaging they are receiving and whether they are receiving the control message or not
Primary Purpose: Health Services Research
Official Title: HPV Message Testing and Social Media Campaign
Actual Study Start Date : December 12, 2018
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Arm Intervention/treatment
Experimental: HPV Messaging
Subjects are randomized to receive one of five messages on one of the four themes about HPV vaccination.
Other: Social Media Message about HPV and HPV vaccine
Messages educate parents with facts about HPV vaccination.

Control Message
Subjects are randomized to receive one of five messages about electronic cigarettes.
Other: Social media message about risk of electronic cigarettes.
Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.




Primary Outcome Measures :
  1. Changes in intention to vaccinate their child with HPV vaccine [ Time Frame: pre test immediately before viewing message and post test immediately after viewing message. Approximately one hour. ]
    Pre and Post surveys of participants viewing a specific social message



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • parents of children 9-14 years old

Exclusion Criteria:

  • non-parents

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03747302


Locations
Layout table for location information
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Norris Cotton Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Ardis L Olson, MD Trustees of Dartmouth College
Principal Investigator: Sun Jung Kim, PhD Massey Cancer Center

Additional Information:
Layout table for additonal information
Responsible Party: Ardis Olson, MD, Physician, Professor of Pediatrics, Trustees of Dartmouth College
ClinicalTrials.gov Identifier: NCT03747302     History of Changes
Other Study ID Numbers: D18180
3P30CA023108-38S4 ( U.S. NIH Grant/Contract )
First Posted: November 20, 2018    Key Record Dates
Last Update Posted: August 14, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ardis Olson, MD, Trustees of Dartmouth College:
Adolescence
Attitudes
Parents
Vaccination
Additional relevant MeSH terms:
Layout table for MeSH terms
Papilloma
Neoplasms, Squamous Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Vaccines
Immunologic Factors
Physiological Effects of Drugs